Abstract
We investigated the delivery of foreign genes into mouse glioma cells in vivo using hemagglutinating virus of Japan (HVJ)-liposomes, which are coated by Sendai virus envelope protein. HVJ-liposomes, containing lacZ gene or herpes simplex virus thymidine kinase (HSVtk) gene-bearing plasmid DNA were applied in the meningeal gliomatosis (MG) mouse model system. Highly efficient delivery was observed in disseminated glioma cells, and 80% of MG mice expressing the HSVtk gene were cured by treatment with ganciclovir. These results suggest that this novel gene delivery system may be applicable for the in vivo gene therapy of human malignant glioma.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mabuchi, E., Shimizu, K., Miyao, Y. et al. Gene delivery by HVJ-liposome in the experimental gene therapy of murine glioma. Gene Ther 4, 768–772 (1997). https://doi.org/10.1038/sj.gt.3300478
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300478
Keywords
This article is cited by
-
Gene therapy as an adjuvant treatment for malignant gliomas: from bench to bedside
Journal of Neuro-Oncology (2009)
-
Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes
Gene Therapy (2000)
-
Widespread gene transfection into the central nervous system of primates
Gene Therapy (2000)